Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants. The unique antibodies target an essential highly conserved site at the base of the virus’s spike protein, effectively clamping it shut and preventing the virus from infecting cells. The findings, published in Nature Communications, offer a promising route to developing broad-spectrum antiviral treatments that could remain effective against future viral variants.
SARS-CoV-2, the virus behind COVID-19, continues to be a potential threat as it evolves into newer variants that are resistant to currently approved antibody therapies. Resistance largely emerges because antibodies typically target virus regions, such as the receptor binding domain of the spike protein, that also frequently mutate, enabling escape from antibody recognition.
To address this, a research team led by Prof. Xavier Saelens and Dr. Bert Schepens at the VIB-UGent Center for Medical Biotechnology explored a different strategy by focusing on one of the more stable subunits of the spike protein. The so-called S2 subunit is critical for the virus’s ability to fuse with host cells, a process essential for infection, and it is more conserved across different coronaviruses.
A molecular clamp on the virus
The team turned to llamas (more specifically a llama called Winter). Llamas generate so-called single-domain antibodies, also known as VHHs or nanobodies, that are much smaller than the antibodies generated by most animals, including humans. The researchers identified several llama antibodies that strongly neutralize a broad panel of SARS coronaviruses.
What makes these antibodies particularly promising is their unique mode of action: they act like a molecular clamp. They latch onto the poorly exposed, highly conserved region (a coiled coil of 3 alpha helices) at the base of the virus’s spike protein. In doing so, they lock the spike protein in its original shape, physically preventing it from unfolding into the form the virus needs to infect cells.
The antibodies showed strong protection against infection in lab animals, even at low doses. And when researchers attempted to force the virus to evolve resistance, the virus struggled, producing only rare escape variants that were much less infectious. This points to a powerful, hard-to-evade treatment option.
This region is so crucial to the virus that it can’t easily mutate without weakening the virus itself. That gives us a rare advantage: a target that’s both essential and stable across variants.”
Prof. Xavier Saelens, senior author of the study
Better treatments
This discovery marks a significant advancement in the quest for durable and broadly effective antiviral therapies, offering hope for treatments that can keep pace with viral evolution.
“The combination of high potency, broad activity against numerous viral variants, and a high barrier to resistance is incredibly promising,” adds Saelens. “This work provides a strong foundation for developing next-generation antibodies that could be vital in combating not only current but also future coronavirus threats.”
De Cae, S., et al. (2025). Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base. Nature Communications. doi.org/10.1038/s41467-025-60250-1
News
Experimental Drug Reverses PTSD Symptoms in Mice – Already in Human Trials
Excessive levels of GABA released by astrocytes impair the brain’s ability to extinguish fear responses in PTSD, but a newly identified drug target offers promising hope for treatment. Many people with post-traumatic stress disorder (PTSD) [...]
New high-selectivity nanozyme enables rapid and visible disease diagnostics
To enable early diagnosis of acute illnesses and effective management of chronic conditions, point-of-care testing (POCT) technology—diagnostics conducted near the patient—is drawing global attention. The key to POCT lies in enzymes that recognize and [...]
Globally, over 2.5 million COVID deaths prevented worldwide thanks to vaccines
Thanks to vaccinations against SARS-CoV-2 in the period 2020–2024, 2.533 million deaths were prevented at the global level; one death was avoided for every 5,400 doses of vaccine administered. Some 82% of the lives [...]
RNA-seq outperforms DNA methods in detecting actionable cancer mutations
Hospital for Sick Children in Toronto researchers are reporting that targeted RNA sequencing can detect clinically actionable alterations in 87% of tumors and provide decisive findings where DNA-seq either fails, returns no variant, or [...]
Physicists discover new state of quantum matter
Researchers at the University of California, Irvine have discovered a new state of quantum matter. The state exists within a material that the team reports could lead to a new era of self-charging computers [...]
Researchers create safer nonstick surface, cutting use of ‘forever chemicals’
A new material developed by researchers from University of Toronto Engineering could offer a safer alternative to the nonstick chemicals commonly used in cookware and other applications. The new substance repels both water and [...]
New research identifies critical gene for treatment
Amyotrophic lateral sclerosis (ALS) - which you may know as the disease that affected Stephen Hawking - is a fatal neurodegenerative disease that causes progressive muscle weakness. A research team at Tohoku University and [...]
DNA Nanoflower Targets Breast Cancer Cells in Drug Delivery Breakthrough
Scientists have developed a DNA nanoflower that delivers chemotherapy and gene therapy directly to breast cancer cells, boosting effectiveness while reducing side effects in early tests. Breast cancer continues to be one of the most [...]
New method genetically blocks mosquitoes from transmitting malaria
Mosquitoes kill more people each year than any other animal. In 2023, the blood-sucking insects infected a reported 263 million people with malaria, leading to nearly 600,000 deaths, 80% of which were children. Recent [...]
How Covid led to an ‘acceleration’ in brain ageing (even if you didn’t have the virus)
The Covid pandemic 'significantly' accelerated brain ageing – even among those who were never infected, a study suggests. Scientists say the strain on people's lives, from isolation for weeks on end to the uncertainty surrounding [...]
Novel Sonication Method Creates Realistic Nanoplastics for Pollution Research
Scientists have developed a simple sonication method to create nanoplastics that closely mimic environmental particles, promising more realistic studies of their ecological impact. Plastics like polyethylene, PET, and polystyrene are used worldwide. Through wear [...]
Pfizer’s COVID-19 Vaccine May Lead to Serious Eye Damage, New Study Reveals
A new Turkish study has raised concerns that Pfizer-BioNTech's COVID-19 vaccine may have subtle but serious side effects on the cornea. The research examined changes in the corneas of at least 64 patients before [...]
Old chemistry unlocks safer and stronger mRNA delivery
As millions of people know firsthand, the most common side effect of mRNA vaccines like the COVID-19 shot is inflammation: soreness, redness and a day or two of malaise. But what if mRNA vaccines [...]
New mRNA vaccine strategy awakens immune system to fight cancer
An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system against [...]
Specially engineered antibody delivers RNA therapy to treatment-resistant tumors
Elias Quijano, PhD; Diana Martinez-Saucedo, PhD; Zaira Ianniello, PhD; and Natasha Pinto-Medici, PhD, there are 25 other contributors, most from Yale's Department of Therapeutic Radiology and from the departments of genetics, molecular biophysics and [...]
Vaccinated women face fewer cervical cancer risks
New data from Denmark shows the HPV vaccine’s powerful long-term impact, while also revealing why cervical cancer screening is still essential. A Danish study published in the journal Eurosurveillance reports that women who received the human [...]
